Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
USI Corporation (1304.TW)
Kaohsiung, TW
USI Corporation operates as a globally active enterprise involved in the creation, production, and sale of a diverse spectrum of chemical and plastic items across continents including Asia, North America, Europe, Africa, and Oceania. Its core business centers on manufacturing various polyethylene types, such as low-density, high-density, and linear low-density resins, as well as ethylene vinyl acetate. The company's comprehensive product lineup extends to vinyl chloride monomer, PVC powder, plastic pellets, polystyrene, and acrylonitrile-butadiene-styrene (ABS) copolymer resins. Additionally, USI produces specialized materials like glass wool products and manganese-zinc soft ferrite powder and cores. Its offerings also encompass a variety of finished plastic goods, including tubes, stretch films, embossed films, industrial multi-layer wraps, plastic cloths, skins, and powders, alongside consumer products such as vest bags, garbage bags, and diapers. Beyond manufacturing, USI provides a range of services, including business management consulting, warehousing for petrochemical raw materials, and commission agency. The company also engages in extensive import and export trade, the distribution of chemical raw materials, the manufacturing of reinforced plastic products, and the wholesale of electronic materials. These products are marketed under established brand names such as EVATHENE, PAXOTHENE, UNITHENE, LINATHENE, and ViviOn. Originally incorporated in 1965 as USI Far East Corporation, USI Corporation's headquarters are located in Kaohsiung, Taiwan.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | -0.78% | -20.06% | +6.69% | +15.91% | +14.86% | +20.28% | -45.63% | -58.20% | +8.70% | -5.27% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%-13.4% Q1'26: -11.5% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%-30.0% Q1'26: +30.5% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%-3.3% Q1'26: -4.0% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%-6.0% Q1'26: -5.9% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%-5.9% Q1'26: -5.0% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+0.1% Q1'26: +0.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×2,530.58× Q1'26: -8.28× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
58.13B
est: 58.73B (-1.0%)
|
60.89B
est: 58.73B (+3.7%)
|
55.66B
est: 55.36B (+0.5%)
|
50.20B
est: 49.53B (+1.4%)
|
71.76B
est: 67.64B (+6.1%)
|
66.44B
est: 67.74B (-1.9%)
|
52.26B
est: 51.81B (+0.9%)
|
51.01B
est: 51.15B (-0.3%)
|
44.17B
est: 44.46B (-0.7%)
|
45.72B
45.72B – 45.72B
+2.8% YoY
|
47.94B
47.94B – 47.94B
+4.9% YoY
|
| EBITDA |
5.63B
est: 8.03B (-29.9%)
|
4.74B
est: 8.03B (-41.0%)
|
5.85B
est: 7.57B (-22.7%)
|
9.82B
est: 6.77B (+45.0%)
|
15.94B
est: 9.25B (+72.4%)
|
9.43B
est: 9.26B (+1.9%)
|
5.02B
est: 5.06B (-0.7%)
|
1.41B
est: 4.99B (-71.7%)
|
8.23M
est: 4.34B (-99.8%)
|
4.46B
4.46B – 4.46B
+2.8% YoY
|
4.68B
4.68B – 4.68B
+4.9% YoY
|
| EBIT |
3.73B
est: 5.50B (-32.1%)
|
2.73B
est: 5.50B (-50.2%)
|
3.66B
est: 5.18B (-29.4%)
|
7.51B
est: 4.63B (+62.0%)
|
13.65B
est: 6.33B (+115.6%)
|
7.07B
est: 6.34B (+11.5%)
|
2.46B
est: 2.68B (-8.3%)
|
-1.29B
est: 2.64B (-148.7%)
|
-2.65B
est: 2.30B (-215.5%)
|
2.36B
2.36B – 2.36B
+2.8% YoY
|
2.48B
2.48B – 2.48B
+4.9% YoY
|
| Net Income |
1.11B
est: 1.04B (+6.8%)
|
539.94M
est: 1.33B (-59.4%)
|
1.28B
est: 1.28B (+0.4%)
|
2.41B
est: 2.10B (+14.7%)
|
5.19B
est: 4.54B (+14.3%)
|
1.56B
est: 1.27B (+22.9%)
|
-207.01M
est: -783.70M (+73.6%)
|
-2.15B
est: -1.61B (-33.4%)
|
-6.41B
est: -2.32B (-176.3%)
|
-4.23B
-4.23B – -4.23B
-82.4% YoY
|
—
— – —
+100.0% YoY
|
| SGA |
3.36B
est: 3.98B (-15.7%)
|
3.44B
est: 3.98B (-13.7%)
|
3.38B
est: 3.76B (-9.9%)
|
3.22B
est: 3.36B (-4.2%)
|
4.44B
est: 4.59B (-3.2%)
|
4.77B
est: 4.60B (+3.7%)
|
3.52B
est: 3.66B (-3.8%)
|
3.78B
est: 3.61B (+4.7%)
|
3.44B
est: 3.14B (+9.7%)
|
3.23B
3.23B – 3.23B
+2.8% YoY
|
3.38B
3.38B – 3.38B
+4.9% YoY
|
| EPS |
1.04
est: 0.97 (+7.1%)
|
0.50
est: 1.24 (-59.7%)
|
1.20
est: 1.19 (+0.8%)
|
2.25
est: 1.96 (+14.8%)
|
4.84
est: 4.24 (+14.3%)
|
1.45
est: 1.18 (+22.9%)
|
-0.19
est: -0.73 (+74.0%)
|
-2.00
est: -1.50 (-33.3%)
|
-2.60
est: -2.16 (-20.4%)
|
-3.94
-3.94 – -3.94
-82.4% YoY
|
—
— – —
+100.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-06 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-05 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-04 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-30 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-29 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-28 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-27 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-24 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-23 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-22 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-21 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-17 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-16 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | State Street SPDR S&P Emerging Markets Small Cap ETF EWX | 0.03% | 210.8K | 0.65% |
| 2 | Avantis Emerging Markets Small Cap Equity ETF AVEE | 0.03% | 34.9K | 0.42% |
| 3 | Dimensional - Emerging Markets ex China Core Equity ETF DEXC | 0.01% | 40.0K | 0.56% |
| 4 | Dimensional Emerging Markets Sustainability Core 1 ETF DFSE | 0.01% | 54.0K | 0.44% |
| 5 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.01% | 959.7K | 0.06% |
| 6 | Avantis Emerging Markets Equity UCITS ETF USD Acc AVEM.L | 0.01% | 14.2K | 0.35% |
| 7 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 447.8K | 0.39% |
| 8 | Dimensional - Emerging Core Equity Market ETF DFAE | 0.00% | 269.2K | 0.29% |
| 9 | Avantis Responsible Emerging Markets Equity ETF AVSE | 0.00% | 6.2K | 0.33% |
| 10 | Vanguard FTSE Emerging Markets Shares ETF VGE.AX | 0.00% | 30.8K | 0.48% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Yi-Gui Wu | Chairman & Chief Executive Officer | 12M | male |
| Pei-Chi Wu | President, GM & Representative Director | 6M | male |
| Ming-Tsung Wu | Deputy General Manager of Business | 4M | male |
| Kuo Lung Tseng | Sales Director | 3M | male |
| Yung-Chih Chen | Head of Legal Division & Corporation Governance Officer | — | male |
| Hun-Yeu Lai | Chief Information Security Officer | — | — |
| Wen-Li Yang | Chief Financial Officer | — | male |
| Chuan-Hua Kuo | Chief Accounting Officer | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 1304.TW
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
